CVE:SQD

SQI Diagnostics Competitors

C$0.25
-0.05 (-15.25 %)
(As of 04/21/2021 09:56 AM ET)
Add
Compare
Today's Range
C$0.25
Now: C$0.25
C$0.28
50-Day Range
C$0.27
MA: C$0.33
C$0.42
52-Week Range
C$0.09
Now: C$0.25
C$0.55
Volume15,163 shs
Average Volume209,853 shs
Market CapitalizationC$85.17 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

SQI Diagnostics (CVE:SQD) Vs. LXG, SVA, GEN, LMD, VPT, and IDL

Should you be buying SQD stock or one of its competitors? Companies in the industry of "diagnostics & research" are considered alternatives and competitors to SQI Diagnostics, including LexaGene (LXG), Sernova (SVA), GeneNews (GEN), LED Medical Diagnostics (LMD), VentriPoint Diagnostics (VPT), and Imaging Dynamics (IDL).

LexaGene (CVE:LXG) and SQI Diagnostics (CVE:SQD) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, risk, earnings and profitability.

Profitability

This table compares LexaGene and SQI Diagnostics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
LexaGeneN/AN/AN/A
SQI DiagnosticsN/AN/AN/A

Valuation & Earnings

This table compares LexaGene and SQI Diagnostics' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LexaGeneN/AN/AN/AC($0.12)-5.55
SQI DiagnosticsC$977,000.0087.18C$-12,264,984.00C($0.04)-6.94

LexaGene has higher earnings, but lower revenue than SQI Diagnostics. SQI Diagnostics is trading at a lower price-to-earnings ratio than LexaGene, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings for LexaGene and SQI Diagnostics, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
LexaGene0000N/A
SQI Diagnostics0000N/A

Summary

SQI Diagnostics beats LexaGene on 2 of the 3 factors compared between the two stocks.

Sernova (CVE:SVA) and SQI Diagnostics (CVE:SQD) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Sernova and SQI Diagnostics, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sernova0000N/A
SQI Diagnostics0000N/A

Profitability

This table compares Sernova and SQI Diagnostics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SernovaN/AN/AN/A
SQI DiagnosticsN/AN/AN/A

Valuation and Earnings

This table compares Sernova and SQI Diagnostics' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/AN/AC($0.03)-55.56
SQI DiagnosticsC$977,000.0087.18C$-12,264,984.00C($0.04)-6.94

Sernova has higher earnings, but lower revenue than SQI Diagnostics. Sernova is trading at a lower price-to-earnings ratio than SQI Diagnostics, indicating that it is currently the more affordable of the two stocks.

Summary

SQI Diagnostics beats Sernova on 2 of the 3 factors compared between the two stocks.

GeneNews (TSE:GEN) and SQI Diagnostics (CVE:SQD) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for GeneNews and SQI Diagnostics, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
GeneNews0000N/A
SQI Diagnostics0000N/A

Earnings & Valuation

This table compares GeneNews and SQI Diagnostics' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GeneNewsC$234,592.000.00C$-11,557,484.00C($0.07)N/A
SQI DiagnosticsC$977,000.0087.18C$-12,264,984.00C($0.04)-6.94

GeneNews has higher earnings, but lower revenue than SQI Diagnostics. SQI Diagnostics is trading at a lower price-to-earnings ratio than GeneNews, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares GeneNews and SQI Diagnostics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
GeneNewsN/AN/AN/A
SQI DiagnosticsN/AN/AN/A

SQI Diagnostics (CVE:SQD) and LED Medical Diagnostics (CVE:LMD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, profitability and analyst recommendations.

Analyst Ratings

This is a breakdown of current recommendations and price targets for SQI Diagnostics and LED Medical Diagnostics, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
SQI Diagnostics0000N/A
LED Medical Diagnostics0000N/A

Profitability

This table compares SQI Diagnostics and LED Medical Diagnostics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SQI DiagnosticsN/AN/AN/A
LED Medical DiagnosticsN/AN/AN/A

Valuation and Earnings

This table compares SQI Diagnostics and LED Medical Diagnostics' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SQI DiagnosticsC$977,000.0087.18C$-12,264,984.00C($0.04)-6.94
LED Medical DiagnosticsC$14.96 million1.04C$-1,512,615.00C($0.04)-10.26

LED Medical Diagnostics has higher revenue and earnings than SQI Diagnostics. LED Medical Diagnostics is trading at a lower price-to-earnings ratio than SQI Diagnostics, indicating that it is currently the more affordable of the two stocks.

Summary

SQI Diagnostics beats LED Medical Diagnostics on 3 of the 5 factors compared between the two stocks.

VentriPoint Diagnostics (CVE:VPT) and SQI Diagnostics (CVE:SQD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, dividends, analyst recommendations, institutional ownership and profitability.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for VentriPoint Diagnostics and SQI Diagnostics, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
VentriPoint Diagnostics0000N/A
SQI Diagnostics0000N/A

Profitability

This table compares VentriPoint Diagnostics and SQI Diagnostics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
VentriPoint DiagnosticsN/AN/AN/A
SQI DiagnosticsN/AN/AN/A

Earnings and Valuation

This table compares VentriPoint Diagnostics and SQI Diagnostics' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VentriPoint DiagnosticsC$37,517.001,867.27C$-4,128,201.00C($0.03)-16.97
SQI DiagnosticsC$977,000.0087.18C$-12,264,984.00C($0.04)-6.94

VentriPoint Diagnostics has higher earnings, but lower revenue than SQI Diagnostics. VentriPoint Diagnostics is trading at a lower price-to-earnings ratio than SQI Diagnostics, indicating that it is currently the more affordable of the two stocks.

Summary

VentriPoint Diagnostics beats SQI Diagnostics on 3 of the 5 factors compared between the two stocks.

Imaging Dynamics (CVE:IDL) and SQI Diagnostics (CVE:SQD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.

Earnings & Valuation

This table compares Imaging Dynamics and SQI Diagnostics' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Imaging DynamicsC$378,253.0040.98C$-3,927,129.00C($0.02)-3.95
SQI DiagnosticsC$977,000.0087.18C$-12,264,984.00C($0.04)-6.94

Imaging Dynamics has higher earnings, but lower revenue than SQI Diagnostics. SQI Diagnostics is trading at a lower price-to-earnings ratio than Imaging Dynamics, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Imaging Dynamics and SQI Diagnostics, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Imaging Dynamics0000N/A
SQI Diagnostics0000N/A

Profitability

This table compares Imaging Dynamics and SQI Diagnostics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Imaging DynamicsN/AN/AN/A
SQI DiagnosticsN/AN/AN/A

Summary

Imaging Dynamics beats SQI Diagnostics on 3 of the 5 factors compared between the two stocks.


SQI Diagnostics Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
LXG
LexaGene
0.5$0.66-3.0%C$83.27 millionN/A-5.55
SVA
Sernova
0.5$1.50-2.0%C$31.35 millionN/A-55.56
GEN
GeneNews
0.5N/AN/AC$24.65 millionC$234,592.00-2.21
LMD
LED Medical Diagnostics
0.4$0.40-100.0%C$15.51 millionC$14.96 million-10.26Gap Down
VPT
VentriPoint Diagnostics
0.6$0.56-0.0%C$5.58 millionC$37,517.00-16.97
IDL
Imaging Dynamics
0.4$0.08-13.3%C$4.13 millionC$378,253.00-3.95Gap Down
DXD
3D Signatures
0.5$0.04-100.0%C$2.66 millionN/A-0.91Gap Down
MBI
Med Biogene
0.5$0.05-22.2%C$795,000.00N/A-7.50Gap Up
BUX
(BUX)
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
IME
12144
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
CRL
Charles River Laboratories International
0.5N/AN/A$0.00N/A0.00Gap Up
SENS
Senseonics
0.0N/AN/A$0.00N/A0.00High Trading Volume
This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.